(Q33953840)

30 July 2017

title

Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study (English)

1 reference

30 July 2017

1 reference

7

Hironobu Sasano

1 reference

30 July 2017

5

Yasuhiro Miki

1 reference

30 July 2017

1

Shuji Nagasaki

1 reference

30 July 2017

6

Yukiko Shibahara

1 reference

30 July 2017

3

Mariko Masuda

1 reference

30 July 2017

Youichi Nakano

2

1 reference

30 July 2017

Katsuhiko Ono

series ordinal

4

1 reference

30 July 2017

publication date

8 July 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

109

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

934-940

1 reference

Epidemiologic survey of lower urinary tract symptoms in Japan

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Storage and voiding symptoms: pathophysiologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Therapeutic receptor targets for lower urinary tract dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Muscarinic receptor antagonists for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Functional evidence of nitrergic neurotransmission in the human urinary bladder neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Effects of nitric oxide on human and canine prostates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Nitric oxide activates ATP-sensitive potassium channels in mammalian sensory neurons: action by direct S-nitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Targeting afferent hyperexcitability for therapy of the painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Characterization and functional role of androgen-dependent PDE5 activity in the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

On the origins of the sensory output from the bladder: the concept of afferent noise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

cGMP-generating cells in the bladder wall: identification of distinct networks of interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Endogenous nitric oxide/cGMP signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

cGMP abolishes agonist-induced [Ca(2+)](i) oscillations in human bladder epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10429.X

10.1111/J.1464-410X.2011.10429.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference